Stocks · Health care · Ophthalmic Goods

STAAR SURGICAL CO

STAA Clue Score37
United States Fiscal year ends January CIK 0000718937 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
James E Francese
27 Sep 2022
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
13,075
$75.00
$980.63K
James E Francese
27 Sep 2022
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
15,683
$75.00
$1.18M
James E Francese
27 Sep 2022
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
6,667
$75.00
$500.03K
Keith Holliday
15 Aug 2022
Chief Technology Officer
Sold after exercise
5,000
$106.22
$531.10K
Keith Holliday
15 Aug 2022
Chief Technology Officer
Sold after exercise
11,582
$106.32
$1.23M
Caren L Mason
20 May 2022
President & CEO
Sold after exercise
35,000
$58.48
$2.05M
Caren L Mason
19 May 2022
President & CEO
Sold after exercise
35,000
$57.49
$2.01M
Caren L Mason
18 May 2022
President & CEO
Sold after exercise
35,000
$56.46
$1.98M
Caren L Mason
18 Nov 2021
President & CEO
Sold after exercise
35,000
$113.83
$3.98M
Caren L Mason
17 Nov 2021
President & CEO
Sold after exercise
35,000
$113.83
$3.98M
Caren L Mason
16 Nov 2021
President & CEO
Sold after exercise
35,000
$114.20
$4.00M
Hans-Martin Blickensdoerfer
7 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
29,131
$157.40
$4.59M
Hans-Martin Blickensdoerfer
7 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
11,522
$157.40
$1.81M
Hans-Martin Blickensdoerfer
2 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
17,343
$157.50
$2.73M
Hans-Martin Blickensdoerfer
2 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
11,038
$157.50
$1.74M
Hans-Martin Blickensdoerfer
1 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
17,573
$157.61
$2.77M
Hans-Martin Blickensdoerfer
1 Sep 2021
Sr. VP, Comm. Ops, China
Sold after exercise
8,621
$157.61
$1.36M
James E Francese
18 Aug 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
15,000
$146.91
$2.20M
Samuel J Gesten
12 Aug 2021
Chief Legal Officer
Sold after exercise
29,682
$134.71
$4.00M
Lou Silverman
10 Aug 2021
Director
Sold after exercise
9,921
$145.54
$1.44M
Lou Silverman
10 Aug 2021
Director
Sold after exercise
10,000
$145.56
$1.46M
Lou Silverman
10 Aug 2021
Director
Sold after exercise
10,000
$145.57
$1.46M
Hans-Martin Blickensdoerfer
24 May 2021
Sr. VP, Comm. Ops, China
Sold after exercise
94,855
$130.42
$12.37M
James E Francese
24 May 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
14,500
$130.42
$1.89M
Hans-Martin Blickensdoerfer
21 May 2021
Sr. VP, Comm. Ops, China
Sold after exercise
5,145
$128.00
$658.56K
James E Francese
21 May 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
15,261
$126.83
$1.94M
Graydon C. Hansen
12 May 2021
Sr. VP, Global Operations
Sold after exercise
5,531
$110.74
$612.50K
Graydon C. Hansen
11 May 2021
Sr. VP, Global Operations
Sold after exercise
11,075
$111.61
$1.24M
Caren L Mason
11 May 2021
President & CEO
Sold after exercise
53,500
$110.70
$5.92M
James E Francese
10 May 2021
Sr. VP, Comm. Ops., NA, APAC
Sold after exercise
11,583
$125.72
$1.46M
Showing 250 of 372 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 321
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 44
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 70
Sales at will 94
Transactions with no price 0
Shares from compensation/vesting 3,426,585
Sales filed before the plan box existed 94
History held since 8 Nov 2006